Halozyme reports positive PEGPH20 phase 1 studies data
Study 101 evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics of PEGPH20 as a single agent, while Study 102 assessed multiple-dosing of PEGPH20 in combination with dexamethasone. The results
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.